You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Attention Score in Context
A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
Journal for Immunotherapy of Cancer, November 2013
Howard Burris, Stephen Ansell, John Neumanitis, Geoffrey Weiss, Branimir Sikic, Donald Northfelt, Lana Pilja, Thomas Davis, Michael Yellin, Tibor Keler, Timothy Bullock
The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||1||50%|
|Science communicators (journalists, bloggers, editors)||1||50%|
The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Professor > Associate Professor||1||9%|
|Readers by discipline||Count||As %|
|Agricultural and Biological Sciences||2||18%|
|Immunology and Microbiology||1||9%|
|Medicine and Dentistry||1||9%|
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2013.
All research outputs
of 22,729,647 outputs
Outputs from Journal for Immunotherapy of Cancer
of 2,894 outputs
Outputs of similar age
of 215,614 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
of 42 outputs
Altmetric has tracked 22,729,647 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,894 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,614 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.